Company intelligence / Profile preview
Nordmark Pharma
Uetersen, Schleswig-Holstein, Germanynordmark-pharma.de ↗
- Ownership
- Private
- Employees
- ~550
- Development stage
- Commercial
01
Overview
Nordmark is a global leader in the production of biopharmaceutical active ingredients and finished drug products of biological origin. The company is especially known for its expertise in manufacturing pancreatin and collagenase. Its products are used worldwide for enzyme replacement therapies, wound care, cell isolation applications, and as APIs for other pharmaceutical companies. The company operates under cGMP standards with FDA approval.
- Therapeutic areas
- GastroenterologyCardiovascularDermatology
- Modalities
- ProteinEnzyme replacement therapyRecombinant proteinBiologic
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Recent undisclosed partnership with a North German pharma company to manufacture a therapeutic protein API used in pediatric oncology
Beyond the preview
Go deeper on Nordmark Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nordmark Pharma.